The modified Brief Pain Inventory for Diabetic Peripheral Neuropathy was used to measure ... in the proportion of patients with a success of treatment over the course of 6 months.

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...

Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and ...

Fermion and Simcere Pharma ink partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4: Guangzhou, China Monday, January 20, 2025, 11:00 Hrs [IST] ...

Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...

A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut ...

I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the ...

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.

Does CBD oil for pain really work? Learn more here about the best products on the market and the evidence behind cannabinoids ...

Foot problems span everything from wearing the wrong shoes to having a specific foot shape and acquiring infection or nerve ...

Researchers found spinal disinhibition in people with fibromyalgia, adding new clues about the role of central pain ...

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...